These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4029252)

  • 1. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis.
    Hoensch HP; Balzer K; Dylewizc P; Kirch W; Goebell H; Ohnhaus EE
    Eur J Clin Pharmacol; 1985; 28(4):475-7. PubMed ID: 4029252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial.
    Ghent CN; Carruthers SG
    Gastroenterology; 1988 Feb; 94(2):488-93. PubMed ID: 3275568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term rifampicin administration in primary biliary cirrhosis.
    Bachs L; Parés A; Elena M; Piera C; Rodés J
    Gastroenterology; 1992 Jun; 102(6):2077-80. PubMed ID: 1587427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of primary biliary liver cirrhosis with rifampicin].
    Loginov AS; Reshetniak VI; Petrakov AV
    Ter Arkh; 1993; 65(8):57-62. PubMed ID: 8211805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR; Allen RM; Klatskin G
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP; Pikkarainen P; Sipponen P; Vuori E; Miettinen TA
    Gut; 1981 Nov; 22(11):901-6. PubMed ID: 7308845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
    Buters JT; Zysset T; Reichen J
    Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive familial cholestatic cirrhosis and bile acid metabolism.
    Williams CN; Kaye R; Baker L; Hurwitz R; Senior JR
    J Pediatr; 1972 Sep; 81(3):493-500. PubMed ID: 5049818
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum bile acids in primary biliary cirrhosis.
    Murphy GM; Ross A; Billing BH
    Gut; 1972 Mar; 13(3):201-6. PubMed ID: 5024725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt sulphation in man. Liver bile salt sulphotransferase activity in patients with primary biliary cirrhosis.
    Lööf L; Nyberg A
    Ups J Med Sci; 1983; 88(1):1-8. PubMed ID: 6575490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of cholestanol in primary biliary cirrhosis.
    Gylling H; Vuoristo M; Färkkilä M; Miettinen TA
    J Hepatol; 1996 Apr; 24(4):444-51. PubMed ID: 8738731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
    Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
    Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
    Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
    Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
    Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
    Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK; Salen G; Abroon J
    Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
    Kowdley KV; Knox TA; Kaplan MM
    Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.